{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:12:51Z","timestamp":1773148371057,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T00:00:00Z","timestamp":1273190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11255-010-9743-6","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T06:37:27Z","timestamp":1273127847000},"page":"835-839","source":"Crossref","is-referenced-by-count":2,"title":["Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Sylvie","family":"Dusilova Sulkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Horacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Zivny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Rehorkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miloslav","family":"Podhola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Kadlec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ctibor","family":"Povysil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,7]]},"reference":[{"key":"9743_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"9743_CR2","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ, Bilezikian JP (2003) \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 88:5348\u20135352","journal-title":"J Clin Endocrinol Metab"},{"key":"9743_CR3","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR et al (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrin Metab 92:3001\u20133005","journal-title":"J Clin Endocrin Metab"},{"key":"9743_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. New Engl J Med 357:266\u2013281","journal-title":"New Engl J Med"},{"issue":"2A","key":"9743_CR5","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2008.12.004","volume":"122","author":"RR Recker","year":"2009","unstructured":"Recker RR, Lewiecki EM, Miller PD, Reiffel J (2009) Safety of biphosphonates in the treatment of osteoporosis. Am J Med 122(2A):S22\u2013S32","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"9743_CR6","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12(Suppl. 1):6222s\u20136230s","journal-title":"Clin Cancer Res"},{"key":"9743_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2215\/CJN.02550508","volume":"4","author":"ND Toussaint","year":"2009","unstructured":"Toussaint ND, Elder GJ, Kerr PG (2009) Bisphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol 4:221\u2013233","journal-title":"Clin J Am Soc Nephrol"},{"key":"9743_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P et al (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084\u20131093","journal-title":"Kidney Int"},{"key":"9743_CR9","doi-asserted-by":"crossref","first-page":"c112","DOI":"10.1159\/000081552","volume":"98","author":"H Reichel","year":"2004","unstructured":"Reichel H, Roth HJ, Schmidt-Gayk H (2004) Evolution of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients. Nephron Clin Pract 98:c112\u2013c118","journal-title":"Nephron Clin Pract"},{"key":"9743_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2006.02.029","volume":"37","author":"E Cavalier","year":"2006","unstructured":"Cavalier E, Delanaye P, Collette J et al (2006) Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta 37:107\u2013111","journal-title":"Clinica Chimica Acta"},{"key":"9743_CR11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O et al (2007) Vitamin D levels and early mortality among hemodialysis patients. Kidney Int 72:1004\u20131113","journal-title":"Kidney Int"},{"key":"9743_CR12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11255-006-0081-7","volume":"38","author":"H Taskapan","year":"2006","unstructured":"Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38:323\u2013329","journal-title":"Int Urol Nephrol"},{"key":"9743_CR13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11255-008-9509-6","volume":"41","author":"J Bouchard","year":"2009","unstructured":"Bouchard J, Quimet D, Vall\u00e9e M et al (2009) Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporoic populations. Int Urol Nephrol 41:983\u2013988","journal-title":"Int Urol Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-010-9743-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9743-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:55:34Z","timestamp":1559390134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-010-9743-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,7]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9743"],"URL":"https:\/\/doi.org\/10.1007\/s11255-010-9743-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,7]]}}}